Jamieson Wellness Inc. Announces Date of Fourth Quarter and Full Year 2023 Financial Results and Conference Call Life Science Investing
Salix Pharmaceuticals Announces a Phase 2 Investigator-Initiated Study of RELISTOR in Patients with Resectable Head and Neck Squamous Cell Carcinoma Pharmaceutical Investing
New Survey Finds More Than Half of Past U.S. Colonoscopy Patients Wish They Had Known More Information About Colonoscopies Including Prep Medication Options and How To Prepare for the Procedure Pharmaceutical Investing
Knight Therapeutics Announces Regulatory Submission of Fostamatinib in Brazil Pharmaceutical Investing
Sirona Biochem Announces Plans for Commercial Launch of GlycoProteMim in Early 2025 Pharmaceutical Investing
Cardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx for Recurrent Pericarditis Geography
